• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CG Oncology, Inc. - Common stock (NQ:CGON)

    41.90 -1.37 (-3.17%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 3, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 900,837
    Open 42.61
    Bid (Size) 40.30 (100)
    Ask (Size) 41.75 (100)
    Prev. Close 43.27
    Today's Range 40.32 - 42.94
    52wk Range 14.80 - 45.56
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why Cg Oncology Stock Rocketed 7% Higher Today
    One pundit believes this is a clinical-stage company well worth watching. 
    Via The Motley Fool
    CG Oncology Stock Signals Bullish Momentum Ahead
    CG Oncology has entered its Phase 2 of the Adhishthana Cycle, signaling a bullish setup. With momentum already building, here's what to track... 
    Via Benzinga

    Performance

    YTD
    +44.6%
    +44.6%
    1 Month
    +5.2%
    +5.2%
    3 Month
    +60.6%
    +60.6%
    6 Month
    +48.7%
    +48.7%
    1 Year
    +13.9%
    +13.9%

    More News

    Read More
    CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months
    From CG Oncology Inc.
    Via GlobeNewswire
    CG Oncology Completes Enrollment in PIVOT-006
    From CG Oncology Inc.
    Via GlobeNewswire
    CG Oncology’s Executive Leadership to Participate in Upcoming Investor Conferences
    From CG Oncology Inc.
    Via GlobeNewswire
    Cg Oncology (CGON) Q2 Loss Widens 93%
    Via The Motley Fool
    CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates
    From CG Oncology Inc.
    Via GlobeNewswire
    Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals
    From CG Oncology Inc.
    Via GlobeNewswire
    Which stocks are moving before the opening bell on Tuesday?
    Via Chartmill
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Beyond The Numbers: 7 Analysts Discuss CG Oncology Stock
    Via Benzinga
    Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
    Via Investor Brand Network
    Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
    Via FinancialNewsMedia
    Topics Death
    Cancer Rates Are Surging in Young Adults — Here’s Where the Smart Money Is Going
    Via FinancialNewsMedia
    CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
    From CG Oncology Inc.
    Via GlobeNewswire
    CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference
    From CG Oncology Inc.
    Via GlobeNewswire
    CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates
    From CG Oncology Inc.
    Via GlobeNewswire
    Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
    Via Benzinga
    Topics Artificial Intelligence
    SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
    From CG Oncology Inc.
    Via GlobeNewswire
    These stocks are moving in today's session
    Via Chartmill
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Crude Oil Down 2%; Roper Technologies Increases 2025 Outlook
    Via Benzinga
    Which stocks are gapping on Monday?
    Via Chartmill
    CG Oncology's Bladder Cancer Drug Impresses Investors - Here's Why
    Via Benzinga
    These stocks are moving in today's pre-market session
    Via Chartmill

    Frequently Asked Questions

    Is CG Oncology, Inc. - Common stock publicly traded?
    Yes, CG Oncology, Inc. - Common stock is publicly traded.
    What exchange does CG Oncology, Inc. - Common stock trade on?
    CG Oncology, Inc. - Common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for CG Oncology, Inc. - Common stock?
    The ticker symbol for CG Oncology, Inc. - Common stock is CGON on the Nasdaq Stock Market
    What is the current price of CG Oncology, Inc. - Common stock?
    The current price of CG Oncology, Inc. - Common stock is 41.90
    When was CG Oncology, Inc. - Common stock last traded?
    The last trade of CG Oncology, Inc. - Common stock was at 11/03/25 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.